Dose Reduction in Thoracic CT

University Health Network, Toronto

Status and phase: Completed; Phase 1

Conditions: Lymphoma

Treatments: Device: CT Thorax

Study type: Interventional

Funder types: Other

Identifiers

NCT00188461

03-0875

Details and patient eligibility

About

Hypothesis: Does a 50% reduction in radiation in dose significantly affect the diagnostic quality of chest CT

Full description

Patients with Lymphoma are recruited and have a follow up CT performed at 50% of the standard exposure parameters. The studies are compared for image quality with a recent (<3 months) thoracic CT performed at standard exposure parameters.

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Lymphoma

Exclusion criteria

• No recent (<3 months) thoracic CT

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)